Convert your Aviptadil dose
Vial
Result
Converted amount0.1 mg
Dose mass100 mcg
Concentration2,500 mcg/mL
Draw volume0.04 mL
U-100 syringe4 units
Reported study ranges
| Purpose | Route | Reported range | Frequency |
|---|---|---|---|
| pulmonary delivery (investigational inhaled/nasal) | nasal | 100–300 mcg | twice daily |
| COVID-19 ARDS / acute respiratory failure (investigational IV protocol) | intravenous | 166–498 ng/kg/hr | continuous infusion over 3 days (escalating) |
Ranges are reported from the literature for research context only. They are not a protocol and not a recommendation.
Concentration by vial and diluent
| Vial | 1 mL diluent | 2 mL diluent | 3 mL diluent |
|---|---|---|---|
| 2 mg | 2,000 mcg/mL | 1,000 mcg/mL | 667 mcg/mL |
| 5 mg | 5,000 mcg/mL | 2,500 mcg/mL | 1,667 mcg/mL |
| 10 mg | 10,000 mcg/mL | 5,000 mcg/mL | 3,333 mcg/mL |
Concentration is vial mass divided by diluent volume. Reconstitution volume changes what you draw, never the dose itself.
What to draw for 100 mcg
| Vial | Diluent | Draw volume | U-100 units | Doses per vial |
|---|---|---|---|---|
| 2 mg | 1 mL | 0.05 mL | 5 units | 20 |
| 2 mg | 2 mL | 0.1 mL | 10 units | 20 |
| 2 mg | 3 mL | 0.15 mL | 15 units | 20 |
| 5 mg | 1 mL | 0.02 mL | 2 units | 50 |
| 5 mg | 2 mL | 0.04 mL | 4 units | 50 |
| 5 mg | 3 mL | 0.06 mL | 6 units | 50 |
| 10 mg | 1 mL | 0.01 mL | 1 units | 100 |
| 10 mg | 2 mL | 0.02 mL | 2 units | 100 |
| 10 mg | 3 mL | 0.03 mL | 3 units | 100 |
Calculated for the low end of the reported pulmonary delivery (investigational inhaled/nasal) range. Change the dose in the calculator above for any other amount.
Aviptadil at a glance
~1–2 minutes (IV; rapidly cleared); designed for continuous infusion
Half-life
3,326.8 Da
Molecular weight
intravenous, nasal
Routes
prescription
Legal status